Prescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate) tablets nationwide due to mislabeling. The recall affects 6,430 cartons distributed throughout the USA.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall for mislabeling only, with no reported adverse events or safety hazard explicitly stated in the source. Class III recalls are typically scored 1 or 2, and a labeling-only issue without reported harm falls at the low end of the scale.
Plain-English summary
Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg in cartons of 28 tablets due to mislabeling. The affected product is NDC 0093-5455-42, manufactured by Barr Laboratories, Inc., in Pomona, NY and distributed nationwide throughout the USA.
The recall affects three specific lots: Lot# 100018610 (expiration 03/2022), Lot# 100021521 (expiration 09/2022), and Lot# 100024575 (expiration 01/2023). A total of 6,430 cartons were distributed.
This is a voluntary recall initiated by Teva Pharmaceuticals USA on January 7, 2022, and classified by the FDA as Class III. Patients currently taking Mimvey should consult their healthcare provider about their medication. The recall was terminated on June 1, 2023.
The recalled product
- Product
- MIMVEY (ESTRADIOL AND NORETHINDRONE ACETATE)
- Brand
- MIMVEY
- Manufacturer
- Teva Pharmaceuticals USA
- Hazard
- Affected units
- 6,430
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: 100018610
- Exp 03/2022
- 100021521
- Exp 09/2022
- 100024575
- Exp 01/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · MIMVEY
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
- SevereMethylprednisolone Acetate Injectable Suspension Lacks Sterility Assurance
FDA (Drugs) · 2022-01-19
- SevereTeva Norepinephrine Bitartrate Injection Recalled for Sterility Assurance
FDA (Drugs) · 2022-01-19
Same hazard · mislabeling
See all →- ModerateOrthofix MINIRAIL External Fixation Devices Incorrectly Labeled
FDA (Devices) · 2026-07-22
- ModerateWise Onion Rings recalled for undeclared food color additives
FDA (Food) · 2026-07-15
- HighBakr Brown Butter Chocolate Chunk Cookie Dough Recalled for Undeclared Soy
FDA (Food) · 2026-07-15
- HighStapes prosthesis pistons carry an incorrect functional length on labeling
FDA (Devices) · 2026-06-10
- HighMedline eye trays contain insulin syringes labeled as tuberculin syringes
FDA (Devices) · 2026-06-03